Terms: = Liver cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Treatment
11 results:
1. [Cytopathological characteristics of smarca4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.
Tomczak A; Springfeld C; Dill MT; Chang DH; Kazdal D; Wagner U; Mehrabi A; Brockschmidt A; Luedde T; Naumann P; Stenzinger A; Schirmacher P; Longerich T
Br J Cancer; 2022 Nov; 127(9):1701-1708. PubMed ID: 35986087
[TBL] [Abstract] [Full Text] [Related]
3. STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
Di Federico A; De Giglio A; Parisi C; Gelsomino F
Eur J Cancer; 2021 Nov; 157():108-113. PubMed ID: 34500370
[TBL] [Abstract] [Full Text] [Related]
4. BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting smarca4.
Choi HI; An GY; Baek M; Yoo E; Chai JC; Lee YS; Jung KH; Chai YG
Sci Rep; 2021 Jun; 11(1):11799. PubMed ID: 34083693
[TBL] [Abstract] [Full Text] [Related]
5. Undifferentiated colonic neoplasm with smarca4 germline gene mutation and loss of smarca4 protein expression: a case report and literature review.
Duan H; Gao W; Wang L; Cao F; Teng L
Diagn Pathol; 2021 Apr; 16(1):30. PubMed ID: 33836796
[TBL] [Abstract] [Full Text] [Related]
6. NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.
Van Treeck BJ; Thangaiah JJ; Torres-Mora J; Stevens TM; Rothermundt C; Fassan M; Loupakis F; Diebold J; Hornick JL; Halling KC; Folpe AL
Mod Pathol; 2021 Aug; 34(8):1547-1557. PubMed ID: 33714983
[TBL] [Abstract] [Full Text] [Related]
7. Brahma-Related Gene 1 Inhibition Prevents liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion.
Zhou Y; Chen Y; Zhang X; Xu Q; Wu Z; Cao X; Shao M; Shu Y; Lv T; Lu C; Xie M; Wen T; Yang J; Shi Y; Bu H
Hepatology; 2021 Aug; 74(2):797-815. PubMed ID: 33650193
[TBL] [Abstract] [Full Text] [Related]
8. smarca4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract] [Full Text] [Related]
9. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
10. Hepatic smarca4 predicts HCC recurrence and promotes tumour cell proliferation by regulating SMAD6 expression.
Chen Z; Lu X; Jia D; Jing Y; Chen D; Wang Q; Zhao F; Li J; Yao M; Cong W; He X
Cell Death Dis; 2018 Jan; 9(2):59. PubMed ID: 29352111
[TBL] [Abstract] [Full Text] [Related]
11. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
[TBL] [Abstract] [Full Text] [Related]
